Active Ingredient History

  • Now
Carteolol is a nonselective beta-adrenoceptor blocking agent for ophthalmic use. It has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. It may be used alone or in combination with other intraocular pressure lowering medications. The following adverse reactions have been reported: transient eye irritation, burning, tearing, conjunctival hyperemia and edema. Carteolol may cause bradycardia and decreased blood pressure, headache, arrhythmia, syncope, heart block, cerebral vascular accident, cerebral ischemia, congestive heart failure, palpitation, nausea, depression. Carteolol should be used with caution in patients who are receiving a beta-adrenergic blocking agent orally, because of the potential for additive effects on systemic beta-blockade.   NCATS

  • SMILES: CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12
  • Mol. Mass: 292.38
  • ALogP: 1.7
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$0.3870 - $1.2720
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

abbott-43326 | cartelol | carteolol | carteolol hcl | carteolol hydrochloride | carteololum | cartrol | dl-carteolol | ocupress | opc-1085 | teoptic


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue